Topic 384: CancerCostDetox: Detoxing Cancer Care Financial Toxicity

主题 384：CancerCostDetox：排毒癌症护理财务毒性

• 批准号: 10018202
• 负责人: Niina Haas
• 金额: $ 30万
• 依托单位: BRIGHTOUTCOME INC.
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-16 至 2020-06-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10018202
• 关键词: Address; Algorithms; Caregiver support; Clinic; Decision Making; Decision Support Systems; Effectiveness; Evaluation; Feedback; Financial Hardship; Goals; Insurance; Link; Outcome Study; Outpatients; Patient risk; Patient-Centered Care; Patients; Process; Resources; System; base; cancer care; cancer therapy; care costs; cost; design; financial toxicity; prototype; usability

The prohibitive cost of cancer care has been widely described. Cancer treatment received by patients with insurance can still result in a considerable financial burden. Non-adherence is one of the best-studied outcomes resulting from higher care costs. Financial distress has also been linked to changes in treatment related decision making, including the decision against a treatment course because of cost. Addressing the costs of cancer care in the clinic is now described as a component of high-quality patient-centered care. Our overarching goal is to develop and evaluate CancerCostDetox, a cancer care decision support system with special focus on assessing patients’ risk in financial hardship, calculating patients’ out-of-pocket costs for different treatment options and facilitating the comparison of treatment options in terms of both effectiveness and cost, and providing tailored financial resources in alleviating the financial burden.

癌症治疗的高昂费用已被广泛描述。有保险的患者接受的癌症治疗仍然会造成相当大的经济负担。不依从性是研究最多的结果之一，由更高的护理成本。财务困境也与治疗相关决策的变化有关，包括由于费用而决定不接受治疗。解决诊所癌症护理的成本现在被描述为高质量以患者为中心的护理的一个组成部分。我们的总体目标是开发和评估CancerCostDetox，这是一个癌症护理决策支持系统，特别侧重于评估患者的经济困难风险，计算不同治疗方案的患者自付费用，并促进治疗方案在有效性和成本方面的比较，以及提供量身定制的财务资源以减轻经济负担。